Total Payments
$2,604
2024 Payments
$187.23
Companies
12
Transactions
52
Medicare Patients
125
Medicare Billing
$705,927
Payment Breakdown by Category
Food & Beverage$1,395 (53.6%)
Consulting$1,206 (46.3%)
Education$3.31 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,395 | 47 | 53.6% |
| Consulting Fee | $1,206 | 1 | 46.3% |
| Education | $3.31 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $1,602 | 9 | $0 (2024) |
| Janssen Biotech, Inc. | $506.79 | 22 | $0 (2021) |
| ABBVIE INC. | $205.93 | 6 | $0 (2022) |
| Ironwood Pharmaceuticals, Inc | $88.39 | 1 | $0 (2023) |
| Amgen Inc. | $59.48 | 3 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $43.29 | 2 | $0 (2019) |
| Concordia Pharmaceuticals Inc. | $25.68 | 1 | $0 (2019) |
| Daiichi Sankyo Inc. | $24.29 | 1 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $18.16 | 1 | $0 (2022) |
| PFIZER INC. | $16.01 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $187.23 | 5 | GENZYME CORPORATION ($131.28) |
| 2023 | $1,523 | 6 | GENZYME CORPORATION ($1,435) |
| 2022 | $34.68 | 2 | Regeneron Healthcare Solutions, Inc. ($18.16) |
| 2021 | $39.14 | 2 | Janssen Biotech, Inc. ($19.60) |
| 2019 | $306.19 | 15 | AbbVie, Inc. ($149.20) |
| 2018 | $266.02 | 12 | Janssen Biotech, Inc. ($176.48) |
| 2017 | $247.74 | 10 | Janssen Biotech, Inc. ($247.74) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/25/2024 | Amgen Inc. | ACTIMMUNE (Biological) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Bone/Inflammation/Rare Disease | ||||||
| 07/25/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $17.12 | General |
| 06/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.45 | General |
| Category: Immunology | ||||||
| 02/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $123.83 | General |
| Category: Immunology | ||||||
| 01/26/2024 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20, COMIRNATY | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: VACCINES | ||||||
| 11/17/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $48.57 | General |
| Category: Immunology | ||||||
| 10/17/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $1,206.00 | General |
| Category: Immunology | ||||||
| 10/06/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $88.39 | General |
| Category: GI | ||||||
| 06/09/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $66.66 | General |
| Category: Immunology | ||||||
| 03/24/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Immunology | ||||||
| 01/11/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $97.90 | General |
| Category: Immunology | ||||||
| 08/10/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/29/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: IMMUNOLOGY | ||||||
| 12/01/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Immunology | ||||||
| 03/03/2021 | Amgen Inc. | AVSOLA (Biological) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Inflammation | ||||||
| 08/29/2019 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.25 | General |
| 08/27/2019 | Retrophin, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 08/27/2019 | Retrophin, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $0.82 | General |
| Category: Hepatology | ||||||
| 07/31/2019 | Concordia Pharmaceuticals Inc. | DONNATAL (Drug) | Food and Beverage | Cash or cash equivalent | $25.68 | General |
| Category: Gastrology | ||||||
| 06/26/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Immunology | ||||||
| 04/23/2019 | Retrophin, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 04/23/2019 | Retrophin, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 04/16/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $109.00 | General |
| Category: Immunology | ||||||
| 04/10/2019 | GENZYME CORPORATION | GAUCHER-DISEASE (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| 03/05/2019 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $10.87 | General |
| Category: THERAPY FOR CSID | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 41 | 18,963 | $858,345 | $325,429 |
| 2022 | 3 | 43 | 12,649 | $577,658 | $206,896 |
| 2021 | 2 | 30 | 10,236 | $463,224 | $172,481 |
| 2020 | 1 | 11 | 17 | $3,247 | $1,120 |
Total Patients
125
Total Services
41,865
Medicare Billing
$705,927
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 18 | 18,900 | $845,586 | $321,663 | 38.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 23 | 63 | $12,759 | $3,766 | 29.5% |
| J3380 | Injection, vedolizumab, 1 mg | Office | 2022 | 16 | 12,600 | $563,724 | $202,100 | 35.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 14 | 25 | $9,350 | $3,267 | 34.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 13 | 24 | $4,584 | $1,529 | 33.4% |
| J3380 | Injection, vedolizumab, 1 mg | Office | 2021 | 15 | 10,200 | $456,348 | $169,850 | 37.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 15 | 36 | $6,876 | $2,631 | 38.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2020 | 11 | 17 | $3,247 | $1,120 | 34.5% |
About Dr. Dahye Hong, M.D
Dr. Dahye Hong, M.D is a Pediatrics healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2010. The National Provider Identifier (NPI) number assigned to this provider is 1811214844.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dahye Hong, M.D has received a total of $2,604 in payments from pharmaceutical and medical device companies, with $187.23 received in 2024. These payments were reported across 52 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,395).
As a Medicare-enrolled provider, Hong has provided services to 125 Medicare beneficiaries, totaling 41,865 services with total Medicare billing of $705,927. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatric Gastroenterology
- Location Washington, DC
- Active Since 04/30/2010
- Last Updated 06/26/2019
- Taxonomy Code 208000000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811214844
Products in Payments
- DUPIXENT (Biological) $1,584
- STELARA (Biological) $250.77
- REMICADE (Biological) $211.57
- Humira (Biological) $189.41
- Linzess (Drug) $88.39
- SIMPONI ARIA (Biological) $33.16
- DONNATAL (Drug) $25.68
- Kanuma (Drug) $25.04
- INJECTAFER (Drug) $24.29
- ACTIMMUNE (Biological) $22.82
- AVSOLA (Biological) $19.54
- CEREZYME (Drug) $18.56
- GAUCHER-DISEASE (Drug) $17.35
- SKYRIZI (Biological) $16.52
- TRUMENBA (Biological) $16.01
- PEDIATRICS (Device) $11.29
- Sucraid (Drug) $10.87
- (820) Cholbam (Drug) $3.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Washington
Helen Thackray, Md, MD
Pediatrics — Payments: $4.6M
Pediatrics $4.6M
Dr. Ikechi Nnawuchi
Pediatrics — Payments: $654,155
Pediatrics $654,155
Michael Guerrera, Md, MD
Pediatrics — Payments: $326,304
Pediatrics $326,304
Brenda Martin, Np, NP
Pediatrics — Payments: $102,882
Pediatrics $102,882
David Nelson
Pediatrics — Payments: $22,971
Pediatrics $22,971
Gary Kupfer
Pediatrics — Payments: $22,067
Pediatrics $22,067